Norwegian medical company enters Singapore collaboration to fight virally induced cancer

… collaboration agreement with Lion TCR (Singapore) on 24 June 2020. According … can be used to develop novel TCR-NK therapies for … TCR-NK products are a novel class of allogeneic cellular therapies … cancer with clinical trials in Singapore and China. For more …